questionnaires
OtherAnxiety and depression questionnaire, life quality questionnaire, adjustment strategy questionnaire, emotional regulation questionnaire, satisfaction survey
NCT Number: NCT01606033
This study aims to assess anxiety/depression and life quality of patients included in clinical trials versus patients treated in a standard way.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oscar Lambret Center, Lille, Hauts-de-France, France
This study aims to assess anxiety/depression and life quality of patients included in clinical trials versus patients treated in a standard way A case-control study
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anxiety and depression questionnaire, life quality questionnaire, adjustment strategy questionnaire, emotional regulation questionnaire, satisfaction survey
understanding of the implications of participating in a clinical trial
Time frame: 4 years
quality of life questionnaire (QLQ C30) Anxiety and depression questionnaire (HADS)
Time frame: 4 years
adjustment therapy questionnaire (WCC) emotional regulation questionnaire (DERS 24)
Time frame: 5 years
emotional regulation (DERS 24)
Time frame: 5 years
assess impact of it on psychological and emotional experience
Centre Oscar Lambret
Other
Psychological and Emotional Impacts of Participation in Oncologic Clinical Trials
Acronym: IPSY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02775292
Adult Solid Neoplasm, Childhood Solid Neoplasm
Los Angeles, California, United States
View Trial DetailsNCT02492711
HER-2 Positive Breast Cancer, Metastatic Neoplasm
Chandler, Arizona, United States
View Trial DetailsNCT00525057
Blood Protein Disorders, Bone Diseases
Houston, Texas, United States
View Trial DetailsNCT07030712
Metastatic Neoplasm, Neoplasm Metastasis
Chicago, Illinois, United States
View Trial Details